Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

115
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

103
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report

Pages

  0-0

Abstract

 Introduction: Coronavirus disease 2019 (COVID-19), started in December 2019, affects many organs and systems of the body, such as the Central Nervous System. Case Presentation: We describe a case of a 66-year-old female patient with positive results for COVID-19 using real-time PCR (RT-PCR) testing from her cerebrospinal fluid (CSF) and the coronavirus antibodies (Ig G and Ig M) using serology test. Her clinical presentation showed the misbalance and acute weakness of upper and lower limbs with preference of proximal parts of the limbs, pinprick, and the absence of deep tendon reflexes. Taken together, these symptoms, neurological tests and the result of CSF analysis (high protein) were in favor of Guillain-Barre syndrome (GBS). In addition, because the neurological symptoms worsted four days after hospitalization, Plasmapheresis was started over the course of 8 days (on every alternate day) with a volume of 2000 mL. Although the results of electromyogram (EMG)-nerve conduction velocity (NCV) following Plasmapheresis showed the motor and sensory neuropathy, which was generally accompanied by demyelination, but it leads to the recovery of upper and lower limbs from 2/5 to 4/5 and improvement of neck flexor muscles from 3/5 to 5/5. Conclusions: GBS should be considered as a neurological outcome of COVID-19. In addition, regarding the beneficial effects of Plasmapheresis on GBS (following coronavirus infection), it can be suggested as a part of the treatment protocol in these patients.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Shaliahmadi, Davood, Bavarsad, Kowsar, MOMENI, MOHAMMAD, Salehi Kahyesh, Roya, & GHAFOURI, SAMIREH. (2021). Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report. JENTASHAPIR JOURNAL OF CELLULAR AND MOLECULAR BIOLOGY (JENTASHAPIR JOURNAL OF HEALTH RESEARCH), 12(1), 0-0. SID. https://sid.ir/paper/692276/en

    Vancouver: Copy

    Shaliahmadi Davood, Bavarsad Kowsar, MOMENI MOHAMMAD, Salehi Kahyesh Roya, GHAFOURI SAMIREH. Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report. JENTASHAPIR JOURNAL OF CELLULAR AND MOLECULAR BIOLOGY (JENTASHAPIR JOURNAL OF HEALTH RESEARCH)[Internet]. 2021;12(1):0-0. Available from: https://sid.ir/paper/692276/en

    IEEE: Copy

    Davood Shaliahmadi, Kowsar Bavarsad, MOHAMMAD MOMENI, Roya Salehi Kahyesh, and SAMIREH GHAFOURI, “Improved a Guillain-Barre Syndrome Patient with Positive PCR Test for Coronavirus in Cerebrospinal Fluid After Plasmapheresis: A Case Report,” JENTASHAPIR JOURNAL OF CELLULAR AND MOLECULAR BIOLOGY (JENTASHAPIR JOURNAL OF HEALTH RESEARCH), vol. 12, no. 1, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/692276/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top